NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









DeepCure

DeepCure

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://deepcure.com/

Last Round

Series A

Extension

Apr 11, 2024

Total Funding Raised

$38.6M

Company Overview

DeepCure is a biotechnology company that develops novel small molecule therapeutics for immune and inflammatory diseases using an AI-driven drug discovery platform.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

ai drug discoverysmall molecule therapeuticsautomated chemistrycomputational drug discoveryin silico drug designmolecular designrobotic laboratorydrug discovery platformde novo designbiotech aipharma r&dlab automationdrug pipelineai chemistry

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

DeepCure Comparables

Compare DeepCure with similar companies based on industry and business-model similarity.

DeepCure comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PostEra
89%
Valo Health
84%
Terray Therapeutics
84%

DeepCure Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionApr 11, 2024
SeedNov 1, 2021

Key People

Founding team and executive leadership

Thrasyvoulos Karydis

Co-Founder And CTO

Founding Team

Kfir Schreiber

Chief Executive Officer, Founder

Founding Team

DeepCure Investors

Notable investors and investment history

DeepCure investors
InvestorRounds
IAG Capital PartnersSeries A Extension
Morningside VenturesSeries A Extension, Seed
TLV PartnersSeries A Extension, Seed
Benon GroupSeries A Extension, Seed
The E14 FundSeries A Extension, Seed
Sapir Venture PartnersSeries A Extension, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2021

    $7M round led by Morningside Ventures

DeepCure Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

DeepCure Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about DeepCure's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range27
Year Founded2018
Last FundingApr 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.